ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,423.205
0.07%
Brent Oil
82.275
-0.21%
Bitcoin
70,226.72
0.14%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Royalty Pharma PLC (RPRX) Share Price

RPRX Royalty Pharma PLC

27.22
-0.26 (-0.95%)
22 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Royalty Pharma PLC NASDAQ:RPRX NASDAQ Common Stock  Class A Ordinary Shares
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.26 -0.95 27.22 27.10 27.23 27.695 27.085 27.33 2,128,469 23:43:57   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 2.35B 1.13B 1.8995 14.30 16.23B
 Type  Size  Price  Time  Units 
 20 200 27.22 23:43:57 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore RPRX News
16/05/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
13/05/202413:15GLOBERoyalty Pharma to Present at Upcoming Investor Conferences
09/05/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202412:17EDGAR2Form 8-K - Current report
09/05/202412:00GLOBERoyalty Pharma Reports First Quarter 2024 Results
09/05/202411:45GLOBERoyalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
19/04/202413:15GLOBERoyalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Period
Draw mode
Data Downloads for RPRX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Royalty Pharma PLC Articles